• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Brachytherapy boosts RFA for lung cancer

Article

Radio-frequency ablation, which has recently been shown to be effective in treating certain lung tumors, might be even more effective in the same population when combined with brachytherapy.

Radio-frequency ablation, which has recently been shown to be effective in treating certain lung tumors, might be even more effective in the same population when combined with brachytherapy.

Brown University researchers treated three patients using the RFA/brachytherapy combination, with a one to 12-month follow-up. They observed tumor shrinkage in the treated area of two patients during follow-up.

RFA-induced tissue necrosis may boost the radioactive seeds' ability to control malignant cells, according to the study published in the September issue of the American Journal of Roentgenology.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.